Expert Opinion on Drug Safety, Volume 14, Issue 9 (2015)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Drug Safety, Volume 14, Issue 9 (2015)

See all volumes and issues
Vol 23, 2024 Vol 22, 2023 Vol 21, 2022 Vol 20, 2021 Vol 19, 2020 Vol 18, 2019 Vol 17, 2018 Vol 16, 2017 Vol 15, 2016 Volume 14, 2015 Vol 13, 2014 Vol 12, 2013 Vol 11, 2012 Vol 10, 2011 Vol 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002
Download citations Download PDFs Download issue

Original Research

Article
Suspected adverse reactions to contrast media in Campania Region (Italy): results from 14 years of post-marketing surveillance
Maurizio Sessa, Claudia Rossi, Annamaria Mascolo, Enrico Grassi, Sonia Fiorentino, Cristina Scavone, Alfonso Reginelli, Antonio Rotondo & Liberata Sportiello
Pages: 1341-1351
Published online: 09 Jul 2015
AbstractforSuspected adverse reactions to contrast media in Campania Region (Italy): results from 14 years of post-marketing surveillance | Full Text | References | PDF (310.2 KB)
  • 230 Views
  • 21 CrossRef citations
  • 0Altmetric

Review

Treatment of severe non-infectious uveitis in high-risk conditions (Part 2): systemic infections; management and safety issues
Miguel Cordero-Coma (Head of the Uveitis Unit) MD PhD FEBOphth, Raquel Salazar-Méndez MD & Taygan Yilmaz
Pages: 1353-1371
Published online: 29 Jun 2015
AbstractforTreatment of severe non-infectious uveitis in high-risk conditions (Part 2): systemic infections; management and safety issues | Full Text | References | PDF (588.1 KB)
  • 206 Views
  • 5 CrossRef citations
  • 0Altmetric
Cardiovascular risk factors, burden of disease and preventive strategies in patients with systemic lupus erythematosus: a literature review
Francesco Benvenuti, Mariele Gatto, Maddalena Larosa, Luca Iaccarino, Leonardo Punzi & Andrea Doria
Pages: 1373-1385
Published online: 27 Jul 2015
AbstractforCardiovascular risk factors, burden of disease and preventive strategies in patients with systemic lupus erythematosus: a literature review | Full Text | References | PDF (313.3 KB)
  • 449 Views
  • 19 CrossRef citations
  • 0Altmetric
The safety of human papilloma virus-blockers and the risk of triggering autoimmune diseases
Britain Baker, Luísa Eça Guimarães, Lucija Tomljenovic, Nancy Agmon-Levin & Yehuda Shoenfeld (Sackler Faculty of Medicine) MD FRCP MaACR
Pages: 1387-1394
Published online: 27 Jul 2015
AbstractforThe safety of human papilloma virus-blockers and the risk of triggering autoimmune diseases | Full Text | References | PDF (189.7 KB)
  • 1096 Views
  • 24 CrossRef citations
  • 0Altmetric
Exploring the safety of chemotherapy for treating breast cancer during pregnancy
Matteo Lambertini, Nermine S Kamal, Fedro A Peccatori, Lucia Del Mastro & Hatem A Azim Jr
Pages: 1395-1408
Published online: 29 Jun 2015
AbstractforExploring the safety of chemotherapy for treating breast cancer during pregnancy | Full Text | References | PDF (392.7 KB)
  • 656 Views
  • 14 CrossRef citations
  • 0Altmetric
Safety reporting through a comprehensive and pragmatic pharmcovigilance process for India and emerging markets: an industry perspective
Shashidhar Swamy (Head Pharmacovigilance) , Meenakshi Mourya (Assistant Manager) , Ganesh Kadhe (AVP-Medical Affairs) , Amey Mane (DGM-Medical Affairs) & Sandesh Sawant (DGM-Medical Affairs)
Pages: 1409-1420
Published online: 19 Aug 2015
AbstractforSafety reporting through a comprehensive and pragmatic pharmcovigilance process for India and emerging markets: an industry perspective | Full Text | References | PDF (668.8 KB)
  • 163 Views
  • 3 CrossRef citations
  • 0Altmetric
Dual antiviral therapy for HIV and hepatitis C – drug interactions and side effects
Isabella Esposito, Pablo Labarga, Pablo Barreiro, José V Fernandez-Montero, Carmen de Mendoza, Laura Benítez-Gutiérrez, José M Peña & Vicente Soriano
Pages: 1421-1434
Published online: 27 Jul 2015
AbstractforDual antiviral therapy for HIV and hepatitis C – drug interactions and side effects | Full Text | References | PDF (396.3 KB)
  • 769 Views
  • 17 CrossRef citations
  • 0Altmetric
Primary biliary cirrhosis: safety and benefits of established and emerging therapies
James H Tabibian & Keith D Lindor (Executive Vice Provost and Dean)
Pages: 1435-1444
Published online: 27 Jul 2015
AbstractforPrimary biliary cirrhosis: safety and benefits of established and emerging therapies | Full Text | References | PDF (458.3 KB)
  • 354 Views
  • 7 CrossRef citations
  • 0Altmetric

Drug Safety Evaluation

Evaluating the safety of Liptruzet (ezetimibe and atorvastatin): what are the potential benefits beyond low-density lipoprotein cholesterol-lowering effect?
Nazik Elmalaika Husain, Abdallah Tarig Hassan, Wadie M Elmadhoun & Mohamed H Ahmed
Pages: 1445-1455
Published online: 02 Jul 2015
AbstractforEvaluating the safety of Liptruzet (ezetimibe and atorvastatin): what are the potential benefits beyond low-density lipoprotein cholesterol-lowering effect? | Full Text | References | PDF (513.1 KB)
  • 725 Views
  • 7 CrossRef citations
  • 0Altmetric
Clinical pharmacokinetics and pharmacodynamics of dolutegravir used as a single tablet regimen for the treatment of HIV-1 infection
Pauline Bollen, Peter Reiss, Jonathan Schapiro & David Burger
Pages: 1457-1472
Published online: 01 Jul 2015
AbstractforClinical pharmacokinetics and pharmacodynamics of dolutegravir used as a single tablet regimen for the treatment of HIV-1 infection | Full Text | References | PDF (506.5 KB)
  • 673 Views
  • 14 CrossRef citations
  • 0Altmetric
Safety of vedolizumab in the treatment of Crohn’s disease and ulcerative colitis
Matilda Hagan MD & Raymond K Cross MD MS
Pages: 1473-1479
Published online: 03 Jul 2015
AbstractforSafety of vedolizumab in the treatment of Crohn’s disease and ulcerative colitis | Full Text | References | PDF (195.6 KB)
  • 834 Views
  • 10 CrossRef citations
  • 0Altmetric
Safety considerations with fenofibrate/simvastatin combination
Theodosios D Filippatos & Moses S Elisaf (Professor of Medicine) MD FRSH FASA FISA
Pages: 1481-1493
Published online: 01 Jul 2015
AbstractforSafety considerations with fenofibrate/simvastatin combination | Full Text | References | PDF (480.4 KB)
  • 531 Views
  • 17 CrossRef citations
  • 0Altmetric

Further Readings

Related articles
Page: 1
Published online: 19 Aug 2015
CitationforRelated articles | Full Text | PDF (96.1 KB)
  • 18 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles